novo nordisk glp-1 receptor agonist medications The FDA approved a pill version of the GLP Novo Nordisk Finds Medicare Patients

Description

Role of gut microbiota in type 2 diabetes pathophysiology

However, human experiments have not proven more than a modest effect on energy expenditure, not achieving clinical significance [28]

C.CarvalhoC

Quality Assessment The results of the quality assessment were visualized using R and the robvis tool (Fig

Substance use disorders An emerging area of interest for GLP-1RAs is their potential role in the treatment of substance use disorders, including alcohol and nicotine dependence.[51] GLP-1 is endogenously produced in the nucleus tractus solitarius of the brainstem and acts as a neuropeptide modulating reward and addiction pathways.[52, 53] GLP-1 receptors are expressed in key regions involved in reinforcement, including the ventral tegmental area and nucleus accumbens, where they modulate glutamatergic signaling, potentially influencing feeding and substance-related behaviors.[53, 54] Though ongoing trials are actively investigating the role of GLP-1RAs in substance use disorders, the current evidence base is constrained by a small number of studies, limited randomized controlled trials, heterogeneity in agents evaluated, and variability in outcome measures.[55] One cohort study of U.S